However, as will also be discussed in this review, there is emerging evidence that interactions of EDCs with other NHRs, notably PPAR-gamma, may coincide with chronic diseases such as obesity and type II diabetes/metabolic syndrome [1,2]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.